Clinical Trials Browser

INDUSTRY × lurtotecan × Thoracic × Clear all

NCT00046787 2011-10-20

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma